Yahoo

Identifying Asian Companies Trading Below Estimated Value In February 2026

As global markets navigate a period of mixed economic signals, Asia's financial landscape presents unique opportunities for discerning investors, particularly in the realm of undervalued stocks. With the Federal Reserve maintaining interest rates and China's stock markets showing little change, identifying companies trading below their estimated value becomes crucial in capitalizing on potential market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In Asia

Name

Current Price

Fair Value (Est)

Discount (Est)

Zhejiang Century Huatong GroupLtd (SZSE:002602)

CN¥19.76

CN¥38.66

48.9%

TLB (KOSDAQ:A356860)

₩59700.00

₩117378.49

49.1%

Thai Coconut (SET:COCOCO)

THB5.45

THB10.84

49.7%

SHIFT (TSE:3697)

¥731.70

¥1459.48

49.9%

Ningxia Building Materials GroupLtd (SHSE:600449)

CN¥13.31

CN¥26.05

48.9%

Medy-Tox (KOSDAQ:A086900)

₩134300.00

₩267720.98

49.8%

Global Security Experts (TSE:4417)

¥2955.00

¥5899.62

49.9%

COVER (TSE:5253)

¥1622.00

¥3197.48

49.3%

Baycurrent (TSE:6532)

¥5441.00

¥10662.90

49%

Akeso (SEHK:9926)

HK$110.40

HK$217.27

49.2%

Click here to see the full list of 255 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Let's take a closer look at a couple of our picks from the screened companies.

Devsisters

Overview:Devsisters Corporation is a developer of mobile games operating in South Korea and internationally, with a market cap of ₩421.60 billion.

Operations:The company generates revenue from its computer graphics segment, amounting to ₩286.10 million.

Estimated Discount To Fair Value:48.6%

Devsisters is trading at ₩38,450, significantly below its estimated future cash flow value of ₩74,806.55. The stock is considered highly undervalued, with a trading price 48.6% beneath its fair value estimate. Despite a recent decline in quarterly earnings and sales compared to the previous year, earnings are forecast to grow significantly over the next three years at 43.7% annually, outpacing the Korean market's growth rate of 31.5%.

KOSDAQ:A194480 Discounted Cash Flow as at Feb 2026
KOSDAQ:A194480 Discounted Cash Flow as at Feb 2026

Air New Zealand

Overview:Air New Zealand Limited operates as an airline providing passenger and cargo transportation across New Zealand, Australia, the Pacific Islands, Asia, the United Kingdom, Europe, and the Americas with a market capitalization of NZ$1.88 billion.

Operations:The company's revenue primarily comes from the transportation of passengers and cargo, amounting to NZ$6.76 billion.

Estimated Discount To Fair Value:19.6%

Air New Zealand is trading at NZ$0.58, 19.6% below its estimated fair value of NZ$0.72, indicating potential undervaluation based on cash flows. Despite a low forecasted Return on Equity of 11.3%, earnings are expected to grow significantly at 26.8% annually, surpassing the New Zealand market's growth rate of 16.6%. Recent operating results show stable passenger numbers and load factors, suggesting resilience in operational performance amid modest revenue growth expectations of 4.5% annually.

NZSE:AIR Discounted Cash Flow as at Feb 2026
NZSE:AIR Discounted Cash Flow as at Feb 2026

UltraGreen.ai

Overview:UltraGreen.ai Limited (SGX:ULG) manufactures fluorescence imaging surgical devices and pharmaceutical agents, with a market cap of $1.85 billion.

Operations:The company's revenue is primarily derived from its Ultralinq segment, contributing $6.84 million, and its DxG segments, with $173.98 million from the Americas and $113.36 million from the Rest of World.

Estimated Discount To Fair Value:23.4%

UltraGreen.ai is trading at US$1.68, 23.4% below its estimated fair value of US$2.19, highlighting potential undervaluation based on cash flows. The company anticipates significant annual earnings growth of 23.7%, outpacing the Singapore market's 7.6%. While revenue growth forecasts are slightly underwhelming at 19.8%, recent regulatory approvals in Southeast Asia could bolster future prospects by expanding access to their fluorescence imaging technologies across key markets like the Philippines and Malaysia, supporting broader clinical adoption.

SGX:ULG Discounted Cash Flow as at Feb 2026
SGX:ULG Discounted Cash Flow as at Feb 2026

Seize The Opportunity

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include KOSDAQ:A194480 NZSE:AIR and SGX:ULG.

This article was originally published by Simply Wall St .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: